Abuse Issues vs. Generics Leads to Petitions, Bill
By Mari Serebrov
Wednesday, August 8, 2012
The FDA could be facing a quandary brought on by the growing epidemic of prescription drug abuse as it tries to balance the need for tamper-resistant painkillers with the demand for access to cheaper generics.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.